Intellectual Property India Publishes Patent Application for 'Antibodies That Bind To C1s And Uses Thereof' Filed by Dianthus Therapeutics Opco, Inc.

MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517055801 A) filed by Dianthus Therapeutics Opco, Inc., New York, on June 10, for 'antibodies that bind to c1s and uses thereof.'

Inventor(s) include Bedian, Vahe; and Omer, Charles A.

The application for the patent was published on July 4, under issue no. 27/2025.

According to the abstract released by the Intellectual Property India: "Embodiments that are provided for herein relate to antibodies and compositions that bind to C1s. Also provided are methods of producing the antibodies of the present disclosure, as well as uses of the provided antibodies and compositions for the treatment of C1s mediated diseases and disorders."

The patent application was internationally filed on Nov. 21, 2023, under International application No.PCT/US2023/080658.

Disclaimer: Curated by HT Syndication.